2016
DOI: 10.1016/j.meegid.2016.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Genetic diversity of subgenotype 2.1 isolates of classical swine fever virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
35
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 46 publications
(37 citation statements)
references
References 25 publications
0
35
0
2
Order By: Relevance
“…Nevertheless, development of new subunit vaccines remains a major area of research with the goal of fulfilling the following: early onset of protection with sterile immunity, long‐lasting immunity (the animal life cycle in the pork industry is about 7–8 months), safety without viral shedding among animals and low‐cost production. Importantly, subunit vaccines provide alternatives to protect pig populations against emerging subgenotypes for which current live attenuated CSFV vaccines are not highly protective, such as the emerging subgenotype 2.1d recently reported in India (Gong et al ., ) and south‐east Asia (Luo et al ., ).…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, development of new subunit vaccines remains a major area of research with the goal of fulfilling the following: early onset of protection with sterile immunity, long‐lasting immunity (the animal life cycle in the pork industry is about 7–8 months), safety without viral shedding among animals and low‐cost production. Importantly, subunit vaccines provide alternatives to protect pig populations against emerging subgenotypes for which current live attenuated CSFV vaccines are not highly protective, such as the emerging subgenotype 2.1d recently reported in India (Gong et al ., ) and south‐east Asia (Luo et al ., ).…”
Section: Discussionmentioning
confidence: 99%
“…In mainland China, CSFV isolates circulating in the late 1980s and 1990s consisted of four subgenotypes (1.1, 2.1, 2.2, and 2.3) (5). More recently, the genetic diversity of subgenotype 2.1 isolates was analyzed, and 10 sub-subgenotypes (2.1a to 2.1j) have been identified (6, 7). A greater understanding of the mechanisms of emergence of subgenotype 2.1 isolates will require analysis of additional complete genomes.…”
Section: Genome Announcementmentioning
confidence: 99%
“…GD317/2011 was isolated from a pig kidney collected from Guangdong, China, in 2011 and classified as sub-subgenotype 2.1i by phylogenetic analysis of the complete E2 gene sequences (6). To obtain the entire genome sequence of this 2.1i isolate, total RNA was extracted from a 10% homogenate of the kidney sample using the TRIzol reagent (Invitrogen, Carlsbad, CA), according to the manufacturer’s instructions.…”
Section: Genome Announcementmentioning
confidence: 99%
“…-6]. It has been reported that subgenotype 2.1 isolates are distributed in many Asian and European countries and play a dominant role in CSF outbreaks occurring in China, Korea and other countries [3,5,7,8]. With more sequences of 2.1 isolates deposited in the GenBank database, CSFV subgenotype 2.1 has been further divided into 10 sub-subgenotypes (2.1a-2.1j) based on a nucleotide sequence of 190-nt and the 1,119-nt E2 gene [8].…”
mentioning
confidence: 99%
“…It has been reported that subgenotype 2.1 isolates are distributed in many Asian and European countries and play a dominant role in CSF outbreaks occurring in China, Korea and other countries [3,5,7,8]. With more sequences of 2.1 isolates deposited in the GenBank database, CSFV subgenotype 2.1 has been further divided into 10 sub-subgenotypes (2.1a-2.1j) based on a nucleotide sequence of 190-nt and the 1,119-nt E2 gene [8]. Except for viruses in the silent sub-subgenotypes (2.1a, 2.1e, and 2.1f), CSFV isolates of subgenotype 2.1 are active and still circulate to cause CSFV infection in domestic pigs and wild boar in many countries, and W. Gong Kidney sample GD19/2011 from a CSF-suspected pig on a pig farm in Guangdong province was collected on July 9, 2011, and submitted to our laboratory for diagnosis.…”
mentioning
confidence: 99%